All About the Newest Research Tool for Prostate Cancer

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

Prostate cancer is a serious problem that affects millions of otherwise healthy people all over the globe. Until now, the most effective means of diagnosis has been to administer a mixture of highly invasive procedures and potentially harmful tests. Well, thanks to an international, collective effort to develop a new research tool for prostate cancer, more and more individuals are now able to maintain proper health in a much easier and more effective way.

What’s New?

The team of Memorial Sloan Kettering researchers who originally developed the new research tool for prostate cancer created the new techniques with the hope that these would allow for more personalized treatment therapy for patients. Using data gathered from the collection of organoids—millimeter-sized, three-dimensional cell groups that resemble an organ or tissue—researchers are more easily able to conduct comprehensive and less invasive tests for the most common forms of prostate cancer. Being able to identify a problem long before it becomes unmanageable is the main objective of this research.

What Does It All Mean?

Up until now, researchers have been using different bodily cell lines in order to conduct their various diagnostic testing for prostate cancer. This has been the primary source of data collection and evaluation for new cancer-fighting drugs as well. With this new technology, being able to identify the various molecular biomarkers that ultimately indicate a drug’s effectiveness is a whole lot easier. At the end of the day, this new research tool for prostate cancer makes precision cancer treatment a real possibility in the near future.

Being able to tell whether or not a cancer treatment drug is still working in the body of a patient without doctors being forced to subject those patients to invasive or inaccurate procedures will change the face of modern medicine. When expert researchers develop organoids directly from the patient’s own prostate cancer samples, the existing tumors are able to be studied in incredible detail. On top of that, the information gathered thereby will help specialists determine the most effective drugs for each individual patient without worry about genetic manipulation or mutation.

What to Do Now

If you think you have, or have been diagnosed with, prostate cancer, now is the time for you to talk to your doctor. Ask him or her about the newest research tool for prostate cancer and give yourself a fighting chance at survival and recovery.